Clinical Trial Update: Single-ascending Dose Study of Kylo-11 in Healthy Subjects [Phase 1]

View source ↗

Summary

Kylonova (Xiamen) Biopharma completed a first-in-human single-ascending-dose Phase 1 study of Kylo-11 in healthy subjects, with the trial geared toward cardiova…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Drugs mentioned

• Kylo-11

Snippet

Sponsor: Kylonova (Xiamen) Biopharma co., LTD. | Conditions: Cardiovascular Diseases | Phase 1 | Status: COMPLETED